Source: Virtual Congress 2021 – Interstitial lung disease around the world



Rating:

Share or cite this content

Citations should be made in the following way:
I. Cox (Hobart, Tasmania, Australia), P. Otahal (Hobart, Tasmania, Australia), B. De Graaff (Hobart, Tasmania, Australia), T. Corte (New South Wales, Australia), E. Walters (Hobart, Tasmania, Australia), A. Palmer (Hobart, Tasmania, Australia). Epidemiology of Idiopathic Pulmonary Fibrosis in Australia. 3758

Member's Comments

No comment yet.

Related content which might interest you: Is Pulmonary Rehabilitation A Savior In Idiopathic Pulmonary Fibrosis? Source: Virtual Congress 2020 – News on diagnosis and therapy of idiopathic pulmonary fibrosis Year: 2020 What can we learn from Idiopathic Pulmonary Fibrosis Registries? Source: International Congress 2018 – The world of idiopathic pulmonary fibrosis (IPF): global registries Year: 2018 Association between Pulmonary Infections and the Prognosis in Patients with Idiopathic Pulmonary Fibrosis Source: Virtual Congress 2021 – Interstitial lung disease around the world Year: 2021 Tele-rehabilitation program in Idiopathic Pulmonary Fibrosis Source: International Congress 2019 – M-health/e-health I Year: 2019 Treatment of Idiopathic Pulmonary Fibrosis Source: Guideline 2015 Year: 2015 LATE-BREAKING ABSTRACT: Epidemiology of IPF in Italy Source: International Congress 2014 – ILDs 6 Year: 2014 Treatment of Idiopathic Pulmonary Fibrosis - Executive Summary Source: Guideline 2015 Year: 2015 Clinical Features and Prognosis of Acute exacerbation of Connective Tissue Diseases Associated Pulmonary Fibrosis------ Comparision with Idiopathic Pulmonary Fibrosis Source: International Congress 2017 – The spectrum of CTDs: from pathogenesis to treatment Year: 2017 Development Of A Machine Learning Combination With Deep Learning For Diagnosing Idiopathic Pulmonary Fibrosis In Chronic Interstitial Lung Disease Source: Virtual Congress 2020 – Predictive markers of progression in connective tissue disease-associated interstitial lung disease and hypersensitivity pneumonitis Year: 2020 Idiopathic Pulmonary Fibrosis: mortality trends in Chile Source: International Congress 2019 – Interstitial lung disease registries Year: 2019 Baseline characteristics of idiopathic pulmonary fibrosis: analysis from the Australian Idiopathic Pulmonary Fibrosis Registry Source: Eur Respir J , 49 (2) 1601592; DOI: 10.1183/13993003.01592-2016 Year: 2017 Bacterial Contamination of Home Nebulizers in Children with Cystic Fibrosis and Clinical Implication on the Number of Pulmonary Exacerbations Source: International Congress 2019 – Infection and inflammation in cystic fibrosis Year: 2019 Treatment of Idiopathic Pulmonary Fibrosis - Evidence to Decision Frameworks Source: Guideline 2015 Year: 2015 The Latin American Idiopathic Pulmonary Fibrosis Registry (REFIPI): Baseline Characteristics Source: International Congress 2019 – Biomarkers of idiopathic interstitial pneumonia Year: 2019 Diffuse pulmonary ossification in Idiopathic Pulmonary Fibrosis: Forli 10-year experience Source: International Congress 2017 – The wide spectrum of ILDs Year: 2017 Platelet activation indices in patients with Idiopathic Pulmonary Fibrosis Source: International Congress 2014 – ILDs 5 Year: 2014 Characterize Idiopathic Pulmonary Fibrosis using Respiratory Oscillometry Source: Virtual Congress 2020 – Real life in the field of idiopathic pulmonary fibrosis: treatments and registries Year: 2020 Ceremony for the ERS Idiopathic Pulmonary Fibrosis Research Award Source: International Congress 2015 – IPF: an airway-derived disease? Year: 2015